Insmed Incorporated (INSM)
NASDAQ: INSM · IEX Real-Time Price · USD
64.50
-1.84 (-2.77%)
At close: Jul 2, 2024, 4:00 PM
64.45
-0.05 (-0.08%)
After-hours: Jul 2, 2024, 7:31 PM EDT
Insmed Revenue
Insmed had revenue of $315.49M in the twelve months ending March 31, 2024, with 22.54% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $75.50M with 15.77% year-over-year growth. In the year 2023, Insmed had annual revenue of $305.21M with 24.39% growth.
Revenue (ttm)
$315.49M
Revenue Growth
+22.54%
P/S Ratio
32.96
Revenue / Employee
$345,936
Employees
912
Market Cap
10.40B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 305.21M | 59.85M | 24.39% |
Dec 31, 2022 | 245.36M | 56.90M | 30.19% |
Dec 31, 2021 | 188.46M | 24.05M | 14.63% |
Dec 31, 2020 | 164.41M | 27.95M | 20.48% |
Dec 31, 2019 | 136.47M | 126.63M | 1,287.56% |
Dec 31, 2018 | 9.84M | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 11.50M | - | - |
Dec 31, 2012 | 0 | - | - |
Dec 31, 2011 | 4.42M | -2.50M | -36.18% |
Dec 31, 2010 | 6.92M | -3.45M | -33.28% |
Dec 31, 2009 | 10.37M | -1.33M | -11.33% |
Dec 31, 2008 | 11.70M | 4.12M | 54.32% |
Dec 31, 2007 | 7.58M | 6.56M | 639.61% |
Dec 31, 2006 | 1.03M | 894.00K | 682.44% |
Dec 31, 2005 | 131.00K | -6.00K | -4.38% |
Dec 31, 2004 | 137.00K | -13.00K | -8.67% |
Dec 31, 2003 | 150.00K | -1.81M | -92.33% |
Dec 31, 2002 | 1.96M | 1.66M | 560.47% |
Dec 31, 2001 | 296.00K | 236.00K | 393.33% |
Dec 31, 2000 | 60.00K | - | - |
Dec 31, 1999 | 0 | - | - |
Dec 31, 1998 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walgreens Boots Alliance | 145.53B |
Fresenius Medical Care AG & Co. KGaA | 21.17B |
Universal Health Services | 14.66B |
Smith & Nephew | 5.55B |
Catalent | 4.14B |
Charles River Laboratories International | 4.11B |
Teleflex | 3.00B |
Bruker | 3.00B |
INSM News
- 5 days ago - Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025 - PRNewsWire
- 21 days ago - Top 4 Health Care Stocks That May Keep You Up At Night This Month - Benzinga
- 25 days ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 27 days ago - Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference - PRNewsWire
- 4 weeks ago - Insmed to Host Commercial Webinar on June 4, 2024 - PRNewsWire
- 4 weeks ago - Insmed Announces Pricing of $650 Million Public Offering of Common Stock - PRNewsWire
- 5 weeks ago - Insmed Announces Proposed $500 Million Public Offering of Common Stock - PRNewsWire
- 5 weeks ago - Insmed Stock More Than Doubled in Value Tuesday—Here's Why - Investopedia